Read + Share
Wykoff CC, Garweg JG, Regillo C, Souied E, et al. KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients
with diabetic macular edema. Am J Ophthalmol 2023 Jul 15:S0002-9394(23)00291.
PMID: 37460036
|
 |
|
Wykoff CC, Garweg JG, Regillo C, Souied E, et al. KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients
with diabetic macular edema. Am J Ophthalmol 2023 Jul 15:S0002-9394(23)00291.
PMID: 37460036
|
|
|
|